Evidence map›Paper›PMID 37579359›Full record

SynthesisInternational journal of health policy and management2023

Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review.

Lotje A Hoogervorst, Timon H Geurkink, Anne Lübbeke, Sergio Buccheri, Jan W Schoones, Marina Torre, Paola Laricchiuta, Paul Piscoi, Alma B Pedersen, Chris P Gale and 6 more

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in International journal of health policy and management, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 7 countries.

Lotje A HoogervorstDepartment of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-5343-6965
Timon H GeurkinkDepartment of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-4290-6161
Anne LübbekeDivision of Orthopaedic Surgery and Traumatology, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Sergio BuccheriDepartment of Cardiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7767-3073
Jan W SchoonesDirectorate of Research Policy (Formerly: Walaeus Library), Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-1120-4781
Marina TorreScientific Secretariat of the Presidency, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0003-3851-187X
Paola LaricchiutaScientific Secretariat of the Presidency, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0001-6892-7185
Paul PiscoiHealth Technology Unit B6, Directorate General for Health (DG SANTE), European Commission, Brussels, Belgium.
Alma B PedersenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-3288-9401
Chris P GaleLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.ORCID 0000-0003-4732-382X
James A SmithBotnar Research Centre and Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Aldo P MaggioniCentro Studi ANMCO, Via Alfonso la Marmora, Florence, Italy.ORCID 0000-0003-2764-6779
Stefan JamesDepartment of Cardiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-4413-9736
Alan G FraserDepartment of Cardiology, University Hospital of Wales, Cardiff, UK.
Rob G H H NelissenDepartment of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-1228-4162
Perla J Marang-van de MheenDepartment of Biomedical Data Sciences & Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-1439-0989
Leiden University Medical Center · NLIstituto Superiore di Sanità · ITUppsala University · SEAarhus University · DKAssociazione Nazionale Medici Cardiologi Ospedalieri · ITEuropean Commission · BENuffield Orthopaedic Centre · GBUniversity Hospital of Wales · GBUniversity of Geneva · CHUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe European Union Medical Device Regulation (MDR) requires manufacturers to undertake post-market clinical follow-up (PMCF) to assess the safety and performance of their devices following approval and Conformité Européenne (CE) marking. The quality and reliability of device registries for this Regulation have not been reported. As part of the Coordinating Research and Evidence for Medical Devices (CORE-MD) project, we identified and reviewed European cardiovascular and orthopaedic registries to assess their structures, methods, and suitability as data sources for regulatory purposes.

methodsRegional, national and multi-country European cardiovascular (coronary stents and valve repair/replacement) and orthopaedic (hip/knee prostheses) registries were identified using a systematic literature search. Annual reports, peer-reviewed publications, and websites were reviewed to extract publicly available information for 33 items related to structure and methodology in six domains and also for reported outcomes.

resultsOf the 20 cardiovascular and 26 orthopaedic registries fulfilling eligibility criteria, a median of 33% (IQR: 14%-71%) items for cardiovascular and 60% (IQR: 28%-100%) items for orthopaedic registries were reported, with large variation across domains. For instance, no cardiovascular and 16 (62%) orthopaedic registries reported patient/ procedure-level completeness. No cardiovascular and 5 (19%) orthopaedic registries reported outlier performances of devices, but each with a different outlier definition. There was large heterogeneity in reporting on items, outcomes, definitions of outcomes, and follow-up durations.

conclusionEuropean cardiovascular and orthopaedic device registries could improve their potential as data sources for regulatory purposes by reaching consensus on standardised reporting of structural and methodological characteristics to judge the quality of the evidence as well as outcomes.

Indexed as

OrthopedicsEquipment SafetyHumansRegistriesReproducibility of ResultsCardiovascularMedical Device RegistriesOrthopaedic

Identifiers

PMID37579359
PMCPMC10702370
OpenAlexW4385202430

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.